Tracie Oliver, Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 18,788 shares at $25.28 ($475K) on 2024-07-02, disclosed to the SEC on 2024-07-03.
Scheduled sale ($475k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.28 | 9,394 | $237K | 50.0% |
| 2 | $25.28 | 9,394 | $237K | 50.0% |
| Total | $25.28 avg | 18,788 | $475K | 100% |
| Filing → |